Paper6402157
Ampicillin and alternatives.
Dyas A and 1 other. Br Med J (Clin Res Ed), 1983. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ampicillin and alternatives. Papers, record 6402157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6402157
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ampicillin | Major topic |
| Humans | |
| Kinetics |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,596,195 | Antimicrobial activity and pharmacological distribution of Wy-4508, an aminoalicyclic penicillin. | Antimicrob Agents Chemother (Bethesda) | 1967 | https://conductscience.org/library/papers/5596195 | PubMed |
| 2 | 5,000,266 | -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation. | Antimicrob Agents Chemother (Bethesda) | 1970 | https://conductscience.org/library/papers/5000266 | PubMed |
| 3 | 4,343,402 | Epicillin: in vitro laboratory studies. | Infect Immun | 1971 | https://conductscience.org/library/papers/4343402 | PubMed |
| 4 | 4,586,142 | Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4586142 | PubMed |
| 5 | 4,357,182 | Serum and urinary concentrations of cyclacillin in humans. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4357182 | PubMed |
| 6 | 4,272,162 | Adverse effects of orally administered ampicillin. | J Pediatr | 1973 | https://conductscience.org/library/papers/4272162 | PubMed |
| 7 | 1,126,306 | Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use. | Drugs | 1975 | https://conductscience.org/library/papers/1126306 | PubMed |
| 8 | 4,680,813 | Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4680813 | PubMed |
| 9 | 1,211,909 | Bacampicillin: a new orally well-absorbed derivative of ampicillin. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1211909 | PubMed |
| 10 | 776,328 | Talampicillin: a new derivative of ampicillin. | Br Med J | 1976 | https://conductscience.org/library/papers/776328 | PubMed |
| 11 | 340,949 | Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. | N Engl J Med | 1978 | https://conductscience.org/library/papers/340949 | PubMed |
| 12 | 371,540 | Double-blind clinical trials of oral cyclacillin and ampicillin. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/371540 | PubMed |
| 13 | 315,930 | Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin chronic bronchitis patients. | Infection | 1979 | https://conductscience.org/library/papers/315930 | PubMed |
| 14 | 7,370,526 | High-dose oral amoxycillin for preventing endocarditis. | Br Med J | 1980 | https://conductscience.org/library/papers/7370526 | PubMed |
| 15 | 7,400,073 | Treatment of domiciliary urinary tract infections with a single dose of amoxycillin. | J Antimicrob Chemother | 1980 | https://conductscience.org/library/papers/7400073 | PubMed |
| 16 | 6,115,119 | Survey of antibiotic prescribing in a district general hospital. I. Pattern of use. | Lancet | 1981 | https://conductscience.org/library/papers/6115119 | PubMed |
| 17 | 6,794,831 | Treatment of urinary tract infection with a single dose of amoxycillin, co-trimoxazole, or trimethoprim.. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6794831 | PubMed |
| 18 | 15,825,310 | Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825310 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 7,691,496 | Penicillins. A current review of their clinical pharmacology and therapeutic use. | Drugs | 1993 | https://conductscience.org/library/papers/7691496 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6402157
GET https://conductscience.org/api/papers/v1/6402157/authors